Your Impact
The Boston Investment Conference has fueled life-changing innovations at Boston Children’s. Thank you for your partnership.
2013 | Infant Brain Monitoring, Ellen Grant, MD
BabyMEG safely and accurately monitors infant brain activity.
2014 | Surgical Simulation, Peter Weinstock, MD, PhD
3D models of each patient’s unique physiology help neurosurgeons tackle the most complex procedures.
2015 | Cancer Diagnosis, Mark Fleming, MD, DPhil
The Laboratory for Molecular Pediatric Pathology deploys next-generation sequencing technology.
2016 | Mitochondrial Therapy, James McCully, PhD
Healthy mitochondria restore damaged heart tissue.
2017 | Blood Stem Cells, Len Zon, MD
Patient-specific blood stem cells are created to treat rare disorders.
2018 | Gene Therapy, Alessandra Biffi, MD
Stem cells delivered directly to the brain accelerate production of genetically corrected cells.
2019 | Customized Therapy, Timothy Yu, MD, PhD
A therapy is created specifically for one child with a rare disease.
2020 | COVID-19 Vaccine, Ofer Levy, MD, PhD
Researchers optimize a coronavirus vaccine for older adults.
2021 | Epilepsy Genetics, Ann Poduri, MD, MPH
Zebrafish models help scientists assess epilepsy drug candidates.
2022 | CAR-T Therapy, Roberto Chiarle, MD
Human trials test powerful personalized treatment for deadly childhood cancer.
2023 | Telomere Therapy, Suneet Agarwal, MD, PhD
Thymidine treatments appear to reverse genetic damage for children with telomere biology disorders.
2024 I Gene Therapy, Jeffrey Holt, PhD
A pioneering treatment restores genetic hearing loss.
2025 I Innovative Cancer Therapy, Hao Wu, PhD
Leverage the body’s own immune system to target and destroy cancer cells more effectively and safely than current treatments.